FindTrial
Sign In

Characterizing disease manifestations and treatment outcome among patients with orofacial granulomatosis: a retrospective study based on medical records

Characterizing disease manifestations and treatment outcome among patients with orofacial granulomatosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000032868
Enrollment
Unknown
Registered
2020-05-14
Start date
2020-05-19
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orofacial granulomatosis

Interventions

non odontogenic infection group (1. inject corticosteroid
2. oral thalidomide) vs odontogenic infection group (1. dental treatment
2. inject corticosteroid
3. oral thalidomide) :Nil

Sponsors

The National Clinical Research Center for Oral Disease of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 100 Years

Inclusion criteria

Inclusion criteria: All eligible patients, who fulfilled the diagnostic criteria for OFG between 2012 and 2018 were included in this study

Exclusion criteria

Exclusion criteria: The patients who was unwilling to attend.

Design outcomes

Primary

MeasureTime frame
Appearance and colour;—

Countries

China

Contacts

Public ContactWang Xinwen

The School of Stomatology, the Fourth Military Medical University

landw211@163.com+86 029-84772604

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026